Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$14.06 - $16.79 $602,836 - $719,888
42,876 Added 334.24%
55,704 $875,000
Q4 2023

Feb 01, 2024

SELL
$11.67 - $20.73 $348,302 - $618,707
-29,846 Reduced 69.94%
12,828 $207,000
Q3 2023

Nov 02, 2023

SELL
$12.15 - $17.85 $120,795 - $177,464
-9,942 Reduced 18.9%
42,674 $524,000
Q2 2023

Jul 31, 2023

BUY
$14.1 - $19.83 $741,885 - $1.04 Million
52,616 New
52,616 $845,000
Q2 2022

Aug 08, 2022

SELL
$7.06 - $13.97 $937,709 - $1.86 Million
-132,820 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$12.15 - $35.28 $1.61 Million - $4.69 Million
132,820 New
132,820 $1.61 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.06B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Duality Advisers, LP Portfolio

Follow Duality Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Duality Advisers, LP with notifications on news.